VWF and malignant glioma: VWF knock down in VWF-expressing cancer cells (osteosarcoma SAOS2 and malignant glioma U251), as well as exogenous VWF expression in non-expressing cancer cells (osteosarcoma KHOS), confirmed that increased adhesive capacity was directly and significantly influenced by VWF expression.